Clinical Trials Directory

Trials / Completed

CompletedNCT00471731

Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure

Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
72 (actual)
Sponsor
National Eye Institute (NEI) · NIH
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Premature ovarian failure (POF) is known to be associated with an increased risk of ocular surface disease (dry eye), likely due to the reduction of both estrogens and androgens seen in this condition. From preliminary data, we suspect that women with Turners syndrome (45, XO), a genetic abnormality that affects sex hormone levels, are also at increased risk of ocular surface disease. Comparing POF and TS women may allow us to distinguish different mechanisms for ocular surface disease, due to the different etiologies of hormonal (estrogen and androgen) alterations posed by POF and TS.

Detailed description

Premature ovarian failure (POF) is known to be associated with an increased risk of ocular surface disease (dry eye), likely due to the reduction of both estrogens and androgens seen in this condition. From preliminary data, we suspect that women with Turners syndrome (45, XO), a genetic abnormality that affects sex hormone levels, are also at increased risk of ocular surface disease. Comparing POF and TS women may allow us to distinguish different mechanisms for ocular surface disease, due to the different etiologies of hormonal (estrogen and androgen) alterations posed by POF and TS.

Conditions

Timeline

Start date
2007-05-07
Completion
2014-11-13
First posted
2007-05-10
Last updated
2018-02-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00471731. Inclusion in this directory is not an endorsement.